{"cik":1658678,"taxonomy":"us-gaap","tag":"AmortizationOfIntangibleAssets","label":"Amortization of Intangible Assets","description":"The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.","entityName":"BioStem Technologies, Inc.","units":{"USD":[{"start":"2025-01-01","end":"2025-06-30","val":61734,"accn":"0001193125-26-347096","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12"},{"start":"2025-04-01","end":"2025-06-30","val":30867,"accn":"0001193125-26-347096","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q2"},{"start":"2026-01-01","end":"2026-06-30","val":1165154,"accn":"0001193125-26-347096","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12"},{"start":"2026-04-01","end":"2026-06-30","val":653331,"accn":"0001193125-26-347096","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2026Q2"}]}}